BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines

Richard J Bold, Subbu Virudachalam, David J. McConkey

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

BACKGROUND. Programmed cell death (termed apoptosis) regulates normal tissue homeostasis. Loss of local paracrine signals and intercellular adhesion molecules are potent inducers of apoptosis and thereby eliminate normal cells that may have escaped beyond the confines of the local organ environment. Dysregulation in the expression of the BCL2 gene family, the prototypic regulators of apoptosis, is a common occurrence in cancer and imparts resistance to standard triggers of apoptosis. Therefore, the authors sought to examine whether abnormal BCL2 gene family expression correlated with resistance to apoptosis and increased metastatic potential in pancreatic carcinoma. METHODS. The authors examined BCL2 expression and apoptotic sensitivity in three panels of human pancreatic cancer cell lines that possess varying metastatic potential. Stable transfectants were generated that overexpress BCL2. These transfectants were then analyzed for differences in metastasis formation in athymic mice. RESULTS. Among the isogenic panels of pancreatic cancer cell lines, BCL2 expression levels correlated with metastatic potential. Highly metastatic variants of each family of cell lines were more resistant to induction of apoptosis. Finally, using the BCL2 transfectant in a xenograft model, elevated BCL2 expression led to a higher incidence of metastases. CONCLUSIONS. The authors conclude that increased BCL2 expression correlates with apoptotic resistance and metastatic potential; dysregulation of BCL2 expression may be involved in the metastatic progression of pancreatic carcinoma.

Original languageEnglish (US)
Pages (from-to)1122-1129
Number of pages8
JournalCancer
Volume92
Issue number5
DOIs
StatePublished - Sep 1 2001

Fingerprint

Pancreatic Neoplasms
Apoptosis
Cell Line
Neoplasm Metastasis
Gene Expression
Cell Adhesion Molecules
Heterografts
Nude Mice
Homeostasis
Cell Death
Incidence
Neoplasms

Keywords

  • Apoptosis
  • bcl-2
  • BCL2
  • Metastasis
  • Pancreas
  • Pancreatic carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. / Bold, Richard J; Virudachalam, Subbu; McConkey, David J.

In: Cancer, Vol. 92, No. 5, 01.09.2001, p. 1122-1129.

Research output: Contribution to journalArticle

Bold, Richard J ; Virudachalam, Subbu ; McConkey, David J. / BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. In: Cancer. 2001 ; Vol. 92, No. 5. pp. 1122-1129.
@article{25b2080929d04202a04a07160305dcdb,
title = "BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines",
abstract = "BACKGROUND. Programmed cell death (termed apoptosis) regulates normal tissue homeostasis. Loss of local paracrine signals and intercellular adhesion molecules are potent inducers of apoptosis and thereby eliminate normal cells that may have escaped beyond the confines of the local organ environment. Dysregulation in the expression of the BCL2 gene family, the prototypic regulators of apoptosis, is a common occurrence in cancer and imparts resistance to standard triggers of apoptosis. Therefore, the authors sought to examine whether abnormal BCL2 gene family expression correlated with resistance to apoptosis and increased metastatic potential in pancreatic carcinoma. METHODS. The authors examined BCL2 expression and apoptotic sensitivity in three panels of human pancreatic cancer cell lines that possess varying metastatic potential. Stable transfectants were generated that overexpress BCL2. These transfectants were then analyzed for differences in metastasis formation in athymic mice. RESULTS. Among the isogenic panels of pancreatic cancer cell lines, BCL2 expression levels correlated with metastatic potential. Highly metastatic variants of each family of cell lines were more resistant to induction of apoptosis. Finally, using the BCL2 transfectant in a xenograft model, elevated BCL2 expression led to a higher incidence of metastases. CONCLUSIONS. The authors conclude that increased BCL2 expression correlates with apoptotic resistance and metastatic potential; dysregulation of BCL2 expression may be involved in the metastatic progression of pancreatic carcinoma.",
keywords = "Apoptosis, bcl-2, BCL2, Metastasis, Pancreas, Pancreatic carcinoma",
author = "Bold, {Richard J} and Subbu Virudachalam and McConkey, {David J.}",
year = "2001",
month = "9",
day = "1",
doi = "10.1002/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-H",
language = "English (US)",
volume = "92",
pages = "1122--1129",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines

AU - Bold, Richard J

AU - Virudachalam, Subbu

AU - McConkey, David J.

PY - 2001/9/1

Y1 - 2001/9/1

N2 - BACKGROUND. Programmed cell death (termed apoptosis) regulates normal tissue homeostasis. Loss of local paracrine signals and intercellular adhesion molecules are potent inducers of apoptosis and thereby eliminate normal cells that may have escaped beyond the confines of the local organ environment. Dysregulation in the expression of the BCL2 gene family, the prototypic regulators of apoptosis, is a common occurrence in cancer and imparts resistance to standard triggers of apoptosis. Therefore, the authors sought to examine whether abnormal BCL2 gene family expression correlated with resistance to apoptosis and increased metastatic potential in pancreatic carcinoma. METHODS. The authors examined BCL2 expression and apoptotic sensitivity in three panels of human pancreatic cancer cell lines that possess varying metastatic potential. Stable transfectants were generated that overexpress BCL2. These transfectants were then analyzed for differences in metastasis formation in athymic mice. RESULTS. Among the isogenic panels of pancreatic cancer cell lines, BCL2 expression levels correlated with metastatic potential. Highly metastatic variants of each family of cell lines were more resistant to induction of apoptosis. Finally, using the BCL2 transfectant in a xenograft model, elevated BCL2 expression led to a higher incidence of metastases. CONCLUSIONS. The authors conclude that increased BCL2 expression correlates with apoptotic resistance and metastatic potential; dysregulation of BCL2 expression may be involved in the metastatic progression of pancreatic carcinoma.

AB - BACKGROUND. Programmed cell death (termed apoptosis) regulates normal tissue homeostasis. Loss of local paracrine signals and intercellular adhesion molecules are potent inducers of apoptosis and thereby eliminate normal cells that may have escaped beyond the confines of the local organ environment. Dysregulation in the expression of the BCL2 gene family, the prototypic regulators of apoptosis, is a common occurrence in cancer and imparts resistance to standard triggers of apoptosis. Therefore, the authors sought to examine whether abnormal BCL2 gene family expression correlated with resistance to apoptosis and increased metastatic potential in pancreatic carcinoma. METHODS. The authors examined BCL2 expression and apoptotic sensitivity in three panels of human pancreatic cancer cell lines that possess varying metastatic potential. Stable transfectants were generated that overexpress BCL2. These transfectants were then analyzed for differences in metastasis formation in athymic mice. RESULTS. Among the isogenic panels of pancreatic cancer cell lines, BCL2 expression levels correlated with metastatic potential. Highly metastatic variants of each family of cell lines were more resistant to induction of apoptosis. Finally, using the BCL2 transfectant in a xenograft model, elevated BCL2 expression led to a higher incidence of metastases. CONCLUSIONS. The authors conclude that increased BCL2 expression correlates with apoptotic resistance and metastatic potential; dysregulation of BCL2 expression may be involved in the metastatic progression of pancreatic carcinoma.

KW - Apoptosis

KW - bcl-2

KW - BCL2

KW - Metastasis

KW - Pancreas

KW - Pancreatic carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035447423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035447423&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-H

DO - 10.1002/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-H

M3 - Article

C2 - 11571724

AN - SCOPUS:0035447423

VL - 92

SP - 1122

EP - 1129

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -